Category: Latest News
-
U.S. Stocks Move Mostly Lower As Meta, Microsoft Tumble
Stocks moved mostly lower over the course of the trading day on Thursday, with the Dow joining the Nasdaq and the S&P 500 in negative territory after seeing some strength early in the session. After ending Wednesday’s trading at a record closing high, the tech-heavy Nasdaq showed a particularly steep drop, plunging 377.33 points or…
-
Datatec (OTCQX:DTTLY) underlying earnings surge 43% on margin gains
Datatec reported adjusted EBITDA growth of 21.9% to US$129.2m for the six months to August 2025, with underlying earnings per share jumping 43% to 19.3 cents. The South African ICT group’s gross profit rose 11.7% to US$483.4m, with margins expanding across all three divisions as software and services reached 71% of gross invoiced income. Net…
-
Comcast beats Q3 forecasts as wireless strength offsets broadband losses
Comcast Corporation (NASDAQ:CMCSA) posted better-than-expected third-quarter results, with strong gains in its wireless and entertainment divisions helping cushion ongoing broadband subscriber declines. Shares rose 1.5% in premarket trading following the release. The company reported adjusted earnings of $1.12 per share, two cents above analyst estimates, while revenue reached $31.2 billion, topping the $30.7 billion consensus…
-
Crocs shares soar nearly 10% after Q3 earnings and revenue beat forecasts
Crocs Inc. (NASDAQ:CROX) shares jumped 9.7% on Thursday after the casual footwear company delivered third-quarter results that handily beat analyst estimates, even as overall sales declined from a year earlier. The company reported adjusted earnings of $2.92 per share, far exceeding the consensus forecast of $2.36, while revenue reached $996.3 million, topping expectations of $961.61…
-
BorgWarner shares gain 2% after strong Q3 earnings beat and raised 2025 outlook
BorgWarner Inc. (NYSE:BWA) shares rose 2.5% in premarket trading Thursday after the auto parts manufacturer reported stronger-than-expected third-quarter earnings and raised its full-year guidance, despite revenue landing just shy of forecasts. The company posted adjusted earnings of $1.24 per share, topping analyst estimates of $1.17 and up 14% year-over-year. Revenue climbed 4.1% to $3.59 billion,…
-
Omnicell shares climb 4% after strong Q3 beat and raised 2025 outlook
Omnicell, Inc. (NASDAQ:OMCL) shares gained 4.19% in premarket trading Thursday after the healthcare technology company delivered better-than-expected third-quarter results and lifted its full-year guidance on the back of strong demand for its connected medication management systems. The company reported adjusted earnings of $0.51 per share, well above the analyst estimate of $0.36, while revenue reached…
-
Biogen shares drop as full-year guidance cut outweighs strong Q3 results
Biogen Inc. (NASDAQ:BIIB) shares fell 2.6% on Thursday after the biotechnology company trimmed its full-year earnings forecast, overshadowing an otherwise strong third-quarter earnings beat that topped Wall Street estimates on both profit and revenue. The company reported adjusted earnings of $4.81 per share, comfortably above the analyst consensus of $3.88, while revenue reached $2.53 billion,…
-
Bristol-Myers Squibb lifts annual outlook after topping Q3 forecasts
Bristol-Myers Squibb (NYSE:BMY) raised its full-year outlook on Thursday after delivering third-quarter results that exceeded analyst expectations, supported by robust sales from its expanding Growth Portfolio. The pharmaceutical giant reported earnings of $1.63 per share, beating the consensus estimate of $1.52, while revenue rose 3% to $12.2 billion, ahead of forecasts calling for $11.8 billion.…
-
L3Harris Technologies tops Q3 estimates, lifts full-year outlook on strong defense demand
L3Harris Technologies (NYSE:LHX) posted better-than-expected third-quarter results on Thursday, driven by solid organic revenue growth and margin improvement, prompting the defense contractor to raise its full-year 2025 guidance. Shares were up 0.7% in premarket trading following the announcement. The company reported adjusted earnings of $2.70 per share, topping the analyst consensus of $2.59, while revenue…
-
Integra LifeSciences tops profit estimates but trims outlook after revenue shortfall
Integra LifeSciences Holdings Corporation (NASDAQ:IART) posted stronger-than-expected third-quarter earnings on Thursday, but revenue missed forecasts and the company lowered its forward guidance, sending shares down 2.79% in premarket trading. The medical technology firm reported adjusted earnings of $0.54 per share, beating analyst expectations of $0.43, while revenue totaled $402.1 million, below the $414.23 million consensus.…